Feasibility study of ginsenoside Rg1 administrated via intranasal route

Zhongguo Zhongyao Zazhi

Volumn 35, Issue 2, 2010, Pages 229-231

  Chen, Xinmei ^a  

^a Shan Dong Traditional Chinese Medical Uinversity   (China)

Author keywords

Feasibility; Ginsenoside Rg1; Nasal drug delivery

Indexed keywords

ENZYME; GINSENOSIDE RG 1;

ANIMAL EXPERIMENT; ARTICLE; CILIARY MOTILITY; DRUG ABSORPTION; DRUG SAFETY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; NOSE MUCOSA; PERFUSION; PH; TOAD;

ADMINISTRATION, INTRANASAL; ANIMALS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; FEMALE; GINSENOSIDES; MALE; NASAL MUCOSA; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77951269040     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: 10.4268/cjcmm20100226     Document Type: Article

References (9)

1. Xu Q F, Fang X L, Chen D F. Pharmacokinetics and bioavailability of ginsenoside Rb1 and Rg1 from Panax notoginseng in rats [J]. J Ethnopharmacol, 2003, 84(2/3):187.
2. Illum L. Nasal drug delivery: new developments and strategies [J]. Drug Discov Today, 2002, 7(23):1184.
3. Illum L. Nasal drug delivery-possibilities, problems and solution [J]. J Control Release, 2003,87(1/3):187.
4. Hirai S, Yashiki T, Matsuzawa T, et al. Absorption of drugs from the nasal mucosa of rat[J]. Int J pharm, 1981,7:317.